Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ashinsky Metzavod reported for 9 months of 2024 by RAS

10/25/24 AMEZ

Mordovenergosbyt reported for 9 months of 2024 by RAS

10/25/24 MRSB

Startup Find the Job has raised ₽6.6 million in funding

10/25/24 OTCI

Element allowed entry into foreign markets through local investors

10/25/24 ELMT

Inter RAO for 9 months of 2024 increased generation by 7.4%

10/25/24 IRAO

Tambovenergosbyt reported for 9 months of 2024 by RAS

10/25/24 TASB

Inter RAO reported for 9 months of 2024 by RAS

10/25/24 IRAO

UTair reported for 9 months of 2024 by RAS

10/25/24 UTAR

Rusagro plans to finalize redomiciliation by March 2025

10/25/24 AGRO

Delimobil CEO increases stake in the company 1.5 times

10/24/24 DELI